Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts

By Han W.   Murray-Segal L.   Gershenzon A.   Zhang J.   Hodder A.   Pietersz G.   Mottram P.  

Transplant Immunology, Vol. 7, Iss. 4, 1999-12 ,pp. : 207-213

Elsevier

Access to resources Recommend Favorite

Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts

By He G.   Kim O.S.   Thistlethwaite J.R.   Hart J.   Siegel C.T.   Szot G.L.   Newell K.A.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1239-1241

Elsevier

Access to resources Recommend Favorite

Oral administration of alloantigen plus nondepleting Anti-CD4 monoclonal antibody induces indefinite prolongation of fully allogeneic cardiac allografts

By Niimi M.   Ikeda Y.   Shirasugi N.   Shatari T.   Takami H.   Kodaira S.   Matsumoto K.   Hamano K.   Esato K.   Hara M.   Wood K.J.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 259-259

Elsevier

Access to resources Recommend Favorite

Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts - Cellular and Molecular Aspects

By Fu F.   Li W.   Lu L.   Thomson A.W.   Fung J.J.   Qian S.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1244-1244

Elsevier

Access to resources Recommend Favorite

Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4 + regulatory T cells

By Niimi M.   Ikeda Y.   Shirasugi N.   Shatari T.   Takami H.   Kodaira S.   Matsumoto K.   Hamano K.   Esato K.   Hara M.   Wood K.J.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2035-2035

Elsevier

Access to resources Recommend Favorite